NCT07193394 2026-02-23
H3RAKLES
Institut Curie
Phase 2 Recruiting
Clinical Trials
4 trialsNCT05673928 2026-01-21
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT05868226 2025-04-04
PRE-I-SPY-PI
QuantumLeap Healthcare Collaborative
Phase 1 Recruiting
NCT04896320 2023-06-22
2019-101826
Providence Health & Services
Phase 1/2 Withdrawn